These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35513495)

  • 21. Contemporary concepts of autoimmunity and autoimmune diseases.
    Nakamura MC; Nakamura RM
    J Clin Lab Anal; 1992; 6(5):275-89. PubMed ID: 1403347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.
    Herkel J
    Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).
    Datta SK
    Front Immunol; 2021; 12():629807. PubMed ID: 33936042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases.
    Yu X; Mai Y; Wei Y; Yu N; Gao T; Yang J
    Int Immunopharmacol; 2023 Mar; 116():109740. PubMed ID: 36696858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.
    Fasano R; Malerba E; Prete M; Solimando AG; Buonavoglia A; Silvestris N; Leone P; Racanelli V
    Front Immunol; 2021; 12():814155. PubMed ID: 35116039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells: cellular mediators for immunological tolerance.
    Chung CY; Ysebaert D; Berneman ZN; Cools N
    Clin Dev Immunol; 2013; 2013():972865. PubMed ID: 23762100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.
    Thompson AG; Thomas R
    Immunol Cell Biol; 2002 Dec; 80(6):509-19. PubMed ID: 12406384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Body's Own Epitopes among Foreign Ones: T Cells and Autoantigens].
    Shilov ES
    Mol Biol (Mosk); 2019; 53(5):849-859. PubMed ID: 31661483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to immunology and autoimmunity.
    Smith DA; Germolec DR
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):661-5. PubMed ID: 10502528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Application of Nanovaccines in Autoimmune Diseases.
    Tang Y; Li L
    Int J Nanomedicine; 2024; 19():367-388. PubMed ID: 38229706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
    Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
    Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ.
    Invernizzi P
    J Autoimmun; 2013 Oct; 46():1-6. PubMed ID: 24012346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologia Futura: Emerging antigen-specific therapies for autoimmune diseases.
    Sármay G
    Biol Futur; 2021 Mar; 72(1):15-24. PubMed ID: 34554499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic nanoparticles-based approaches for immune tolerance induction in vivo.
    Mao K; Wang J; Xie Q; Yang YG; Shen S; Sun T; Wang J
    J Control Release; 2024 Feb; 366():425-447. PubMed ID: 38154540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.
    Rui Y; Eppler HB; Yanes AA; Jewell CM
    Adv Healthc Mater; 2023 Jan; 12(6):e2202238. PubMed ID: 36417578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral tolerance for the treatment of autoimmune diseases.
    Weiner HL
    Annu Rev Med; 1997; 48():341-51. PubMed ID: 9046967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory CD8+ T cells in autoimmune disease.
    Suzuki M; Konya C; Goronzy JJ; Weyand CM
    Hum Immunol; 2008 Nov; 69(11):781-9. PubMed ID: 18812196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of regulatory cell-based therapy in autoimmune disease.
    Ghobadinezhad F; Ebrahimi N; Mozaffari F; Moradi N; Beiranvand S; Pournazari M; Rezaei-Tazangi F; Khorram R; Afshinpour M; Robino RA; Aref AR; Ferreira LMR
    Front Immunol; 2022; 13():1075813. PubMed ID: 36591309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.